Skip to main content
. 2020 Jun 4;21:e15. doi: 10.1017/S1463423620000092

Table 2.

Prevalence of some measures of polypharmacy, prescribing quality, and potential adverse drug reactions (n = 45)

Measure Prevalence
Number of drugs [mean (range)] 9.8 (4–21)
Five or more drugs [n (%)] 42 (93.3)
Ten or more drugs [n (%)] 20 (44.4)
Inappropriate drugs [n (%)] 2 (4.4)
Drug duplication [n (%)] 1 (2.2)
Drug–drug interactions, Class C [n (%)] 18 (40)
Drug–drug interactions, Class D [n (%)] 0 (0)
Potential adverse drug reactions [mean (range)] 2.7 (0–12)